Phase 1 study of the safety, tolerability, and pharmacokinetics of the β-lactamase inhibitor vaborbactam (RPX7009) in healthy adult subjects - Griffith, D C; Loutit, J S; Morgan, E E; Durso, S; Dudley, M N (Antimicrob Agents Chemother, 2016)